Latest news with #M42
New Indian Express
4 days ago
- Science
- New Indian Express
Indian astronaut Shubhanshu Shukla shares stunning photographs of space
BENGALURU: Indian astronaut Shubhanshu Shukla, who returned from the International Space Station (ISS) recently after completing the Axiom-4 mission with three other astronauts, shared some of his stunning pictures of M42 (aka Orion Nebula), which he had taken from the Bengaluru sky. The Orion Nebula is an interstellar cloud of gas and dust that is located in the Orion constellation. Shux on X said as the photographs clicked on the ISS will take some time to be received, verified and cleared because of the multiple space agencies' involvement, he wanted to share his astrophotography story. 'I started into astrophotography upon returning to India after my first leg of training at the Gagarin Cosmonaut Training Centre (GCTC) in Russia. The pictures in sequence are of the same interstellar object M42 (M Stands for Messier- Name of the catalogue that maintains all night sky objects),' Shux posted. He added that over time, it has gotten better, and it is evident from the last photograph. 'All the pictures were clicked from the night sky of Bengaluru,' he posted on X. Shux, who has turned into an inspiration for students and the youth keen on the space fraternity, posted an encouraging message, 'Slow or fast, if you keep moving, progress is guaranteed.'
Newsweek
23-07-2025
- Health
- Newsweek
How the Future of AI Health Care is Taking Shape in the Middle East
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. For a look at how the health care of the future will be shaped by artificial intelligence and data, Abu Dhabi is a good start. The genetic makeup of most of the local population has been sequenced, allowing anyone's high risk of disease to be detected — and action to be taken — long before symptoms appear. Apps help patients navigate their care, with plans underway to connect them to everything from data delivered by wearable devices to medical records as well as to their doctors. "We use AI to predict conditions and improve medical outcomes and by improving outcomes, we're reducing hospitalization costs, reducing costs for the system," said Dimitris Moulavasilis, the chief executive of M42, a global health care company headquartered in the capital of the United Arab Emirates that underpins the health system there and is expanding rapidly abroad. "We're using genomics data to create population programs, which, again predict conditions, keep people healthy and we are using digital to organize health systems." "I think there is a wish across the globe that we should be able to improve the care delivered and reduce the cost. So how we can move from a reactive, episodic sick care where we are today." Dimitris Moulavasilis, CEO of Abu Dhabi-headquartered global health company M42 Dimitris Moulavasilis, CEO of Abu Dhabi-headquartered global health company M42 Courtesy of M42 Moulavasilis noted that health care costs vary from 7 to 8 percent of GDP in Eastern Europe to as high as 17 percent in the United States, but the costs are growing faster than economic growth rates everywhere. He said some of the biggest beneficiaries of data-driven and AI-powered health care would be in the less wealthy countries of the Global South that are starting from a lower base and can build their health systems in a more effective way. Personalized Treatments "Data plays a role as AI allows for personalized treatments, which allows patients to get treated, or you may predict conditions and patients might not get sick, and you can avoid the potential disease before it happens," he said, adding that it was also important considering increasing longevity. "People want to have a longer health span, not necessarily 200 years, but to live healthily until the end of their biological lives." M42 is already the largest health care group in the Middle East and serves some 15 million patients worldwide with operations in 27 countries. Its revenues have grown five times in the past seven years. M42 highlights examples of specific patients who have already been helped — such as a 40-year-old Emirati woman who was identified as having a 100 percent chance of thyroid cancer because of a gene mutation. She was treated straight away. Then there was the eight-year-old with vision loss, which was again pinned down to a gene mutation and treatment provided. "In Abu Dhabi, we have digitalized all the system. Digitalizing the system is not just applying some technologies, it is designing the systems and applying them. We are the engine behind the health information exchange," Moulavasilis said. M42 has an advantage being based in a center with a commitment to high-tech investment and to becoming a base for research, as well as with possibly the world's most extensive genome program by percentage of people covered — with more than 800,000 of 1.3 million Emiratis already sequenced and the number rising quickly. M42 runs the program in partnership with the Department of Health. Danat Al Emarat Hospital in Abu Dhabi Danat Al Emarat Hospital in Abu Dhabi M42 "They have the metrics, the people, the sophistication, and they are embracing all these new technologies, so we may try to deploy new models of care here, which then, upon the proof of the efficiency and outcomes we may expand globally," Moulavasilis said. "Because we have now all these amazing data sets, we have developed a trusted research environment that with the right privacy for the patient and keeping the data in a sovereign environment, we can extract insights and we can make collaborative research with pharma companies to create new targeted drugs and create new value from the life science space," Moulavasilis said. Genome Database For its genome database, it is recruiting patients across different sectors and genders to make its data sets fully representative, with models trained on different nationalities. At the same time, respect is paid to protecting individuals' and countries' rights to data privacy. M42's operations extend much further than Abu Dhabi. Through acquisitions and organic growth, it now has more than 480 facilities in 26 countries and over 20,000 employees. It foresees annual growth in the future at around 8 to 10 percent. Although M42 is not yet in the United States, it is investigating opportunities for investment there. It is already in most European countries and has a significant presence in Latin America, including Brazil and Chile. It also has a major presence close to home in Saudi Arabia and the Gulf countries. In Uzbekistan, it is collaborating and exploring opportunities for a strategic partnership on the Uzbek Genome Program. "The Global South really is an important space for expansion," Moulavasilis said, particularly after the acquisition of kidney-care provider Diaverum. "We are in discussion with many countries, particularly the Global South." M42's biggest challenge is not technology, it is human nurses and physicians, Moulavasilis said. There again, however, AI helps all to work more effectively. "As the population grows and ages, there's a big amount of nurses who the global national health systems lack today," he said. "Now we're privileged to be perceived as employees of choice because of the use of digital and AI, so nurses can be always very much productive, focusing what they are trained to do like provide care, as opposed to liaise with all the bureaucratic and the routine, non-valuable, mundane activities."
Campaign ME
17-07-2025
- Business
- Campaign ME
Edelman UAE makes key leadership appointments
Edelman has announced new leadership appointments across its UAE team in an effort to reinforce its specialist capabilities in Health, Crisis & Risk, and Brand. These internal moves promotions aim to reflect Edelman's ongoing investment in integrated, sector-led communications and the strength of its senior talent across the region. Lauren Brush has assumed the role of Head of Health, bringing a track record of advising high-profile global stakeholders, including the Saudi Ministry of Health and leading U.S.-based medical associations. Her work spans pandemic response, BRCA testing, and the launch of the UAE's first-ever telemedicine portal. Already a key advisor on Edelman's partnership with M42 and its expansive portfolio, Brush will now lead the development of the firm's health offer in the region, helping clients navigate an increasingly high-impact and rapidly shifting sector. Chase Burns has been appointed Head of Crisis & Risk, expanding his role within Edelman's Corporate Practice. He currently leads the work for the Abu Dhabi Investment Office (ADIO), Hub71 and ATRC. With more than 15 years of experience both in-house and advising clients through high-stakes, reputationally sensitive situations across aviation, advanced technology and sovereign investment, Burns has overseen responses to aircraft groundings, geopolitical attacks, and pandemic-related disruptions. As scrutiny intensifies and exposure to misinformation and disinformation, operational disruption, and geopolitical risks grows, Burns will lead the development of Edelman's integrated crisis and risk advisory services in the region, helping clients anticipate, navigate and recover from complex situations, while also representing the region within Edelman's global crisis leadership team. Lastly, Deepanshi Tandon has been appointed Head of Brand for Edelman UAE. In her role, she will lead the Brand practice, building on Edelman's expertise in creating earned-first, trusted brands that drive influence and shape culture. She brings more than 15 years of experience and has led several global brands across markets and sectors, spearheading strategic, creative, and culturally resonant work. Tandon currently leads work for clients such as PepsiCo and Nissan Middle East and has played a central role in shaping brand reputation strategies and leading integrated, multi-channel campaigns that drive cultural relevance and impact. On the appointments, Omar Qirem, CEO, Edelman Middle East, said: 'These leadership updates reflect both our investment in specialist talent and our commitment to developing leadership from within. Lauren, Chase and Deepanshi bring a powerful combination of subject matter expertise, client trust, and integrated thinking that will be instrumental to our next chapter of growth in the region.' The global communications firm operates wholly owned offices in Abu Dhabi, Dubai, and Riyadh as part of Edelman's broader Middle East network.
BBC News
15-07-2025
- BBC News
Man jailed after £1m of cocaine found in car boot near Alvechurch
A man has been jailed for more than 12 years after police found £1.3m in drugs in the boot of his car following a 120mph chase on the Sherratt, 48, of no fixed address, pleaded guilty to being concerned in the supply of cocaine, possessing the drug with intent to supply, and dangerous was sentenced to 12 years and nine months at Warwick Crown Court on 7 was driving a black Peugeot 3008 when officers from West Midlands Police attempted to pull him over. They believed the car was linked to drugs. Sherratt drove off, reaching speeds of up to 120mph on the southbound side of the M5, before heading onto the followed him in both a car and a vehicle was stung and lost a tyre - Sherratt was subsequently arrested on the M42 near Alvechurch. The force said his boot contained Sports Direct bags, each one holding 18kg of cocaine, with the total value up to £ smashed his phone against the dashboard in what police believe was an attempt to destroy his arrest, he told officers: "Good day at the office, lads."Messages showed he had been involved in the collection of a further 135kg of drugs - worth up to £5m in said he would deliver the drugs around the country, earning up to £2,000 per kilogram."Sherratt's attempt to get away from our officers was dangerous and put other road users at risk, but great work by the road crime team meant the pursuit was brought to a safe conclusion," said Det Ch Insp Peter Cooke."He played a significant role in the distribution of drugs around the country but will now be spending years behind bars."West Mercia Police said he had 12 previous convictions for 19 offences, which date back to was jailed for six years in 2016 for conspiracy to supply Class A drugs and was further jailed for more than four years in 2020 for additional drugs offences. Follow BBC Hereford & Worcester on BBC Sounds, Facebook, X and Instagram.
The Independent
15-07-2025
- The Independent
Drug dealer congratulates police after 120 mph chase and huge cocaine seizure
A drug dealer, David Sherratt, was arrested following a high-speed police pursuit on the M5 and M42 motorways while transporting £1.3 million worth of cocaine. West Midlands police, supported by a helicopter, chased Sherratt's black Peugeot at speeds of 120mph on 17 April before deploying a stinger to halt the vehicle. Officers discovered 36kg of cocaine, with a street value of £1.3 million, concealed in two Sports Direct bags in the car's boot, prompting Sherratt to congratulate them. At Birmingham Crown Court on 7 July, Sherratt received a sentence of 12 years and nine months after pleading guilty to being concerned in the supply of cocaine, possessing the drug with intent to supply, and dangerous driving. Watch the video in full above.
